Novartis’s Brightened Outlook Pushes Shares to All-Time High

(Bloomberg) -- Novartis AG raised its earnings outlook for the second time this year, driving the shares to an all-time high, and said the launch of its $2.1 million gene therapy is on track despit...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.